EGFR and non-small cell lung carcinoma: This study aimed to use a new chip-based dPCR technique platform for the quantification of circulating cfDNA targets (EGFR 19del and T790M) in NSCLC patient serum samples, and to find potential serum biomarkers which may help to screen beneficiary patients and improve the dPCR liquid biopsy detection efficiency.